| KIAA0788 |
ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase |
LSM2 |
LSM2, C6orf28, G7b: U6 snRNA-associated Sm-like protein LSm2 |
105.000 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
105.000 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
105.000 |
Evidence |
O
|
| POLR1C |
POLR1C, POLR1E: DNA-directed RNA polymerases I and III subunit RPAC1 |
POLR2H |
POLR2H: DNA-directed RNA polymerases I, II, and III subunit RPABC3 |
105.000 |
Evidence |
O
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
MTA1 |
MTA1: Metastasis-associated protein MTA1 |
105.000 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
105.000 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
105.000 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
105.000 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
105.000 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
DOK1 |
DOK1: Docking protein 1 |
105.000 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
105.000 |
Evidence |
|
| CRYAA |
CRYAA, CRYA1, HSPB4: Alpha-crystallin A chain |
CRYBB2 |
CRYBB2, CRYB2, CRYB2A: Beta-crystallin B2 |
105.000 |
Evidence |
O
|
| CRYAB |
CRYAB, CRYA2: Alpha-crystallin B chain |
CRYGC |
CRYGC, CRYG3: Gamma-crystallin C |
105.000 |
Evidence |
O
|
| HBZ |
HBZ, HBZ2: Hemoglobin subunit zeta |
HBZ |
HBA1, HBA2: Hemoglobin subunit alpha |
105.000 |
Evidence |
|
| PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
CTRC |
CTRC, CLCR: Chymotrypsin-C precursor |
105.000 |
Evidence |
|
| CPA2 |
CPA2: Carboxypeptidase A2 precursor |
CTRC |
CTRC, CLCR: Chymotrypsin-C precursor |
105.000 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
105.000 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
105.000 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
FSHR |
FSHR, LGR1: Follicle-stimulating hormone receptor precursor |
105.000 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
STAT3 |
|
104.000 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
104.000 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
104.000 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|
- 
-